More than 600 different neurological diseases affect the human population. Some of these
are genetic and can emerge even before birth, and some are caused by defects, infections …

Drug repurposing, also known as drug repositioning or drug reprofiling, involves
establishing new therapeutic indications for a clinically well-established drug. The drug …

The traditional de novo drug discovery is time consuming, costly and in some instances the
drugs will fail to treat the disease which result in a huge loss to the organization. Drug …

Diagnostic and prognostic models based on machine learning models can improve
diagnosis and identification of patients at risk of adverse health outcomes. Healthcare …

Recent challenges in the medical field have emphasized the need to exploit new
technology, starting with the production of medicines and medical devices, to electronic …

Amorphous drugs have gained attention as a promising alternative to crystalline
formulations due to their ability to enhance solubility. However, ensuring the physical …

Diseases like diabetes, heart disease, kidney disease, thyroid disease, and other diseases
are increasing in frequency, and people are suffering globally. Specifically, thyroid and heart …

ABSTRACT The incorporation of Artificial Intelligence (AI) in the pharmaceutical industry has
transformed many elements of drug discovery, development, manufacturing, clinical trials …

A comprehensive overview of the integration of deep learning techniques in drug
repurposing, particularly focusing on the CoV-DrugX module within the CoV-DrugX Pipeline …

Managing the human immunodeficiency virus (HIV) infection poses significant challenges
due to its complex genetic diversity and evolving drug resistance patterns. Artificial …